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Investigation of synthesis and processing of 
cellulose, cellulose acetate and poly(ethylene 
oxide) nanofibers incorporating anti-cancer/tumor 
drug cis-diammineplatinum (II) dichloride using 
electrospinning techniques
Abstract: A model anti-cancer/tumor drug cis-diam-
mineplatinum (II) dichloride (cisplatin) was loaded into 
micro- and nanofibers of cellulose, cellulose acetate (CA) 
and poly(ethylene oxide) (PEO), using various electro-
spinning techniques. Single-nozzle electrospinning was 
used to fabricate neat fibers of each category. Drug load-
ing in cellulose fibers was performed using single-nozzle 
electrospinning. Encapsulation of cisplatin in CA and 
PEO-based fibers was performed using coaxial electro-
spinning. Morphological analysis of the fibers was per-
formed using scanning electron microscopy (SEM) and 
energy dispersive X-ray spectroscopy (EDS). The various 
categories of fibers exhibited diverse morphological fea-
tures depending on the material compositions and applied 
process parameters. The drug-loaded cellulose nanofibers 
showed attached particles on the surface. These particles 
were composed of both the polymer and the drug. The CA-
cisplatin fibers exhibited drug encapsulation within vari-
ous diverse morphological conformations: hierarchical 
structures such as straw-sheaf-shaped particles, dendritic 
branched nanofibers and swollen fibers with large beads. 
However, in the case of PEO fibers, drug encapsulation 
was observed inside repeating dumbbell-shaped struc-
tures. Morphological development of the fibers and cor-
responding mode of drug encapsulation were correlated 
with process parameters such as applied voltage, concen-
trations and relative feed rates of the solutions and con-
ductivities of the solvents.
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1  Introduction
The electrospinning process is a facile method for produc-
tion of micro- and nanoscale fibers from polymer mate-
rials. A charged polymer solution of sufficient viscosity 
suspended from a spinneret is drawn under the influence 
of high electrostatic forces towards a grounded collector. 
Charge repulsion among like charges can overcome the 
surface tension of the droplet above a critical voltage. This 
effect induces the elongation of the droplet into a charac-
teristic Taylor cone, which subsequently leads to jetting 
of the solution into a conical envelope region of complex 
flow instabilities. The electrohydrodynamic jetting com-
bined with the flow instabilities promote thinning of the 
jet along with solvent evaporation – which ultimately 
leads to the formation of solidified nanofibers on the 
 collector [1–5].
The morphological characteristics of nanofibers can 
be tuned or modified by adjusting the electrospinning 
parameters. The wide array of adjustable parameters can 
be divided into three basic categories – solution, process 
and ambient parameters [6]. The solution parameters 
consist of the molecular weight of polymer [7, 8], con-
centration [9–12], viscosity [13, 14] surface tension [15] 
and conductivity [16]. The process parameters consist of 
voltage [17, 18], flow rate [19], collector type [20, 21] and dis-
tance between spinneret tip to collector [22, 23]. Ambient 
parameters such as humidity and temperature can also 
affect fiber morphology [24, 25]. Some of the parameters 
are interrelated to each other such as viscosity, polymer 
concentration and molecular weight. The solution 
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viscosity and related chain entanglement effects can be 
adjusted by choosing a polymer of appropriate molecular 
weight or by adjusting the concentration [26, 27].
The prospect of incorporation or functionalization of 
bioactive agents such as drugs, proteins, enzymes, antibod-
ies etc., with electrospun nanofibers make them versatile 
candidates for development of functional biomaterials 
such as drug delivery devices [28, 29], wound dressings [30] 
and tissue engineering scaffolds [31]. Attractive properties 
of nanofibers such as their extremely high specific surface 
area, ultra-high porosity and diverse morphological char-
acteristics are relevant for such applications. For applica-
tions in development of drug delivery systems, the large 
surface area to volume ratio and high porosity of nanofiber 
membranes overcomes the limitation of high drug uptake 
associated with other types of drug delivery devices. Addi-
tionally, the release mechanism of drugs loaded within 
nanofibers can be adjusted by choosing a suitable polymer 
and also modifying morphological characteristics of the 
nanofibers such as the diameter, porosity and surface fea-
tures. Such modifications can be achieved by adjusting 
the appropriate electrospinning process variables such 
as voltage, solution feed rate, ambient conditions, solu-
tion viscosity, surface tension and conductivity [32]. Drug 
loading into nanofibers can be accomplished by various 
methods such as coating, embedding, or encapsulation. 
Selection of a proper solvent system is also a critical step for 
ensuring stable electrospinning and consistent nanofiber 
production. Simple blending of both the drug and polymer 
dissolved in a mutually compatible solvent is one of the 
methods for preparing solutions for electrospinning. Elec-
trospinning of drug loaded nanofibers was performed by 
Tungprapa and coworkers [28] from a solution of cellulose 
acetate (CA) in N,N-dimethyl acetamide (DMAc) and acetone 
blended with various model drugs. Taepaiboon et al. [29] 
reported electrospinning of drug loaded poly(vinyl alcohol) 
nanofibers using various drugs blended with poly(vinyl 
alcohol) in distilled water. Ranganath and Wang [33] fab-
ricated cancer drug paclitaxel loaded poly(D,L lactide-co-
glycolide) (PLGA) nanofibers by electrospinning a blend 
solution of PLGA dissolved in dichloromethane (DCM) and 
N,N-dimethylformamide (DMF), and mixed with pacli-
taxel. Similar methods of electrospinning using solutions 
with a mutually compatible solvent for both the drug and 
polymer were also reported for fabrication of nanofibers of 
poly-ε-caprolactone (PCL)-polyphosphate containing nerve 
growth factor protein [34], PCL containing heparin [35] and 
PLLA loaded with tetracycline hydrochloride [36]. The drug 
and polymer can also be solubilized in separate solvent 
systems and mixed together. Kim and coworkers used a 
dual solution mixture of PLGA dissolved in DMF along with 
an aqueous solution of cefoxitin sodium dissolved in water 
to prepare cefoxitin loaded PLGA nanofibers [37]. Kenawy 
et  al. [38] reported electrospinning of poly(ethylene-co-
vinyl acetate) and poly(lactic acid) solutions in chloroform 
mixed with tetracycline HCl solution. Chen et al. [39] fab-
ricated composite nanofibers of PLLA loaded with cispla-
tin, using dual solutions of PLLA in DCM and cisplatin in 
DMF. However, these methods of electrospinning using 
drugs blended with polymer solutions renders it difficult 
to ascertain complete encapsulation of the drug inside the 
nanofibers, since some of the drug particles may be par-
tially embedded or exposed to the surface in the resultant 
nanofiber membrane or scaffold. Such approaches are more 
suited for applications where a quicker initial release of 
drugs from the nanofibers is desired. A drug release profile 
with low initial burst release is desirable for sustained and 
controlled delivery of drugs from a biodegradable polymer 
membrane. To overcome issues of drug encapsulation 
with conventional methods, nanofibers of a core-sheath 
morphology produced using coaxial electrospinning can 
be utilized. Separate solutions of drug and polymer can 
be loaded in separate concentric capillaries and coaxially 
electrospun to form nanofibers with a core-shell morphol-
ogy. He and coworkers [40] produced drug-loaded core-
shell nanofibers of PLLA using coaxial electrospinning. The 
sheath solution consisted of PLLA dissolved in chloroform 
and acetone. The core solution consisted of a model drug, 
tetracycline HCl dissolved in a mixture of methanol and 
chloroform with a small amount of PLLA. Huang et al. [41] 
fabricated two types of core-shell PCL nanofibers loaded 
with two model drugs by coaxial electrospinning. PCL dis-
solved in a mixture of chloroform and ethanol was used as 
the sheath solution. Two model drugs, resveratrol dissolved 
in ethanol and gentamycin sulfate in water, were used as 
core solutions. They observed that an increase in drug con-
centration resulted in a decrease in bead defects when drug 
and polymer solutions were miscible (resveratrol-loaded 
nanofibers). The opposite effect was observed when the 
drug and polymer solutions were immiscible (gentamycin 
sulfate loaded nanofibers) [41]. Jiang and coworkers [42] 
prepared biodegradable core-shell nanofibers by coaxial 
electrospinning of poly-DL-lactic acid (PDLLA) and poly(3-
hydroxybutyrate) solutions. They reported the flow-rate 
of core liquid to have a predominant effect on both outer 
and inner fiber diameter. A core-shell structure can shift 
the release mechanism to drug diffusion and matrix deg-
radation rather than desorption from the nanofiber surface 
[32, 43]. Optimum production of core-shell nanofibers can 
be achieved by adjusting parameters such as the relative 
feed rates, conductivity and viscosity of the core and shell 
solutions. Other factors such as the degree of dissimilarity, 
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mutual interfacial interactions and rheological properties 
of the core and shell solutions are also important [42, 44]. 
A modified form of the coaxial electrospinning process for 
the preparation of ketoprofen loaded CA nanofibers was 
reported by Yu et al [45], where they investigated the effects 
of stabilizing the compound electrospinning jet with a non-
spinnable sheath solvent. The core solution consisted of CA 
hybridized with a drug (ketoprofen). The sheath solution 
was a mixture of organic solvents. The core jet is subjected 
to electrical drawing for a longer period, facilitating homo-
geneous core jet solidification and retarding the formation 
of surface defects such as wrinkles on the surface of the 
nanofibers.
The focus of our work was to achieve encapsulation of 
a model drug (cisplatin) inside micro- or nanoscale fibers 
produced from various biocompatible polymers. The 
core solution used in our electrospinning experiments 
consisted of a drug (cisplatin) dissolved in a compatible 
organic solvent (DMF), which cannot be electrospun by 
itself to form fibers. We investigated the usage of a core 
drug solution without hybridizing it with a polymer or 
functionalization, to retain the physical state of the drug 
without further alteration. Coaxial electrospinning with 
a polymer-hybridized drug core and a sheath polymer 
would result in the formation of larger fibers.
One of the key processing issues in coaxial electro-
spinning is the proper selection of core and sheath sol-
vents. However, specialized drugs or pharmaceutical 
agents for cancer treatment generally have a very limited 
range of compatible solvents. For instance, the anti-cancer 
drug cis-diammineplatinum(II) dichloride (cisplatin) is 
compatible with a limited number of solvents (DMF, DMA, 
DMSO). In some cases, a solvent compatible with the drug 
solution can be incompatible with the sheath solvent. As 
such, when both the solutions come in contact with each 
other at the coaxial spinneret tip, undesirable issues such 
as clogging of the spinneret tip due to precipitation of the 
polymer can be observed. Interfacial effects at the phase 
between the incompatible solutions can lead to unbal-
anced charge distributions on the compound solution 
droplet, resulting in the formation of nonuniform fibers 
with several structural defects, resulting in inefficient 
drug encapsulation. Therefore, regarding encapsulation 
of nonhybridized or non-functionalized drugs within a 
polymer matrix, these processing issues can substantially 
increase the complexity of coaxial electrospinning.
In this work, we have utilized the approaches of solu-
tion blending and coaxial electrospinning to prepare 
drug-loaded micro/nanofibers of three different biocom-
patible polymers: cellulose pulp, CA and poly(ethylene 
oxide) (PEO). Neat fibers of each polymer were fabricated 
using single-nozzle electrospinning. For loading of drugs 
in the fibers, the following experiments were performed:
(a) Single-nozzle electrospinning of cellulose pulp 
 dissolved in N-methylmorpholine N-oxide (NMMO.
H2O), combined with a solution of cisplatin dissolved 
in DMF.
(b) Coaxial electrospinning using sheath solutions of (i) 
CA and (ii) PEO. A solution of cisplatin in DMF was 
used as the core solution.
Due to various processing issues involving dissolution and 
compatibility with the drug solution, only single-nozzle 
mode was used for spinning of drug-loaded cellulose pulp 
fibers. Drug encapsulation was performed using coaxial 
spinning for CA and PEO solutions due to their stability at 
ambient conditions, easier processing steps and compat-
ibility with the drug solution.
Comparative morphological analysis of neat and 
drug-loaded fibers of each material system was performed 
using scanning electron microscopy (SEM). Elemental 
analysis using energy dispersive X-ray spectroscopy (EDS) 
was used to verify the presence of cisplatin in the drug-
loaded fibers. These observations provided insight into 
the mode of drug encapsulation in the fibers and assisted 
with the correlation of various process parameters with 
the morphological development of the various categories 
of nanofibers.
2  Materials and methods
The polymers used for fabricating the fibers consisted 
of cellulose pulp (DP 1230), CA (Mw 30,000 g/mol, acetyl 
content 39.8%) and PEO (Mw 100,000 g/mol). The  solvents 
used were NMMO.H2O, acetone, DMAc, DMF and deionized 
water. The anti-cancer drug used was cis-diammineplati-
num (II) dichloride or cisplatin. Other additives consisted 
of sodium chloride (NaCl) salt and propyl gallate, an anti-
oxidant. The polymers, solvents and the drug were pro-
cured from Sigma Aldrich (St. Louis, MO, USA). Cellulose 
pulp was acquired from Georgia-Pacific (GP) cellulose 
(Atlanta, GA, USA). Cisplatin was dissolved in DMF at a 
concentration of 5 mg/ml. DMF was used as the drug solu-
tion. DMF was chosen as the solvent due to its compat-
ibility with cisplatin.
The experiments were performed using a MECC NF-500 
electrospinning unit. The unit consists of dual syringe feed 
pumps, customizable spinneret attachments and a high 
voltage power supply. Neat nanofibers of each category were 
prepared by single-nozzle electrospinning (Figure 1A). The 
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drug-loaded fibers were prepared by coaxial electrospin-
ning (Figure 1B). The specialized coaxial spinneret (Figure 2) 
consisted of a 0.6  mm sheath nozzle and a 27-gauge core 
nozzle placed concentrically inside the sheath nozzle. The 
tip of the core nozzle was extended 0.5 mm below the tip 
of the sheath nozzle. The polymer and drug solutions were 
fed through the sheath and core nozzles, respectively, using 
Teflon tubes connected to individual syringe pumps. The 
positive terminal of a high voltage power source was con-
nected to the body of the spinneret. The ground terminal 
of the power source was connected to a steel plate collec-
tor placed below the spinneret. The steel plate was covered 
with an aluminum foil which was used as the fiber deposi-
tion substrate. The process parameters, voltage, spinneret 
tip-to-collector distance and feed rates, were adjusted by 
using the control unit of the NF-500 system.
Morphological analysis of both the neat and drug-
loaded fibers was performed using a JEOL JSM-7600F scan-
ning electron microscope (JEOL USA, Peabody, MA, USA). 
Elemental analysis for determining the fiber compositions 
was performed using EDS. One centimeter squares of fiber 
samples of each category were cut from the aluminum foil 
substrate and sputter-coated with a layer of gold for obser-
vation in the SEM. Measurements of dimensions of fibers 
and particles were performed using the “ImageJ” (NIH, 
Bethesda, MD, USA) application.
3  Results and discussion
The solution compositions for each type of polymer and 
the drug used for the electrospinning experiments are 
Feed pump
A B Feed pump-1
(sheath)
Feed pump-2
(core)
Spinneret
(loaded with
polymer solution) High voltagepower source
High voltage
power source
Collector plate
Collector plate
Polymer
sheath
Compound
Taylor cone
Drug
particles
Coaxial
spinneret
Figure 1: Electrospinning configurations: (A) single-nozzle, (B) coaxial.
Figure 2: Coaxial spinneret.
shown in Table 1. The relevant electrospinning process 
parameters for each category are shown in Table 2.
A solution of cellulose pulp was prepared using NMMO 
as the solvent. NMMO powder was first dissolved in 10 ml 
of deionized water. Powdered cellulose pulp was then 
added to this solution at a loading of 2 wt%. Antioxidant 
propyl gallate was added at 1 wt% of cellulose, to prevent 
degradation of the cellulose solution during mixing. The 
solution was heated at 40–50°C in a sealed flask connected 
to a vacuum aspirator. Heating in a vacuum environment 
enabled the usage of a lower solution heating temperature 
to boil the water content. The reduction of water content 
is known to enhance the dissolution of cellulose pulp in 
NMMO [46]. A 27-gauge needle was used as the nozzle for 
the spinneret. The blend solution of cellulose and cispla-
tin was not heated while spinning, due to the instability 
of cisplatin solutions at elevated temperatures, where it 
undergoes a cis-trans isomerization. As such, we avoided 
heating the spinneret during single-nozzle spinning to 
avoid changing the physical properties of the drug.
Due to complications in effective dissolution of cellu-
lose pulp in NMMO, the resulting solution had a paste-like 
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viscosity even at low loading levels (2 wt%) of cellulose pulp. 
As such, single-nozzle electrospinning was used for both the 
cellulose pulp solutions with and without drug for easier pro-
cessing. However, the resulting yield of nanofibers was too 
low due to high instability in the electrospinning jet, which 
mostly led to electrospraying of the solution. The nanofiber 
samples were washed with deionized water to extract any 
remaining NMMO solvent and to precipitate the cellulose 
fibers. The spinning parameters are listed in Table 2.
SEM images of neat cellulose nanofibers showed an 
interconnected web of nanofibers of 70–90 nm, as shown 
in Figure 3. However, the nanofibers were discontinuous 
and showed many surface defects. Electrospinning of the 
cellulose-cisplatin solution yielded a very low volume of 
production of fibers. SEM images of fibers of this category 
did not exhibit any encapsulation of the cisplatin particles 
within the fibers. Aggregated particles of cellulose and cis-
platin were observed on the surface of the fibers, as shown 
in Figure 4A. EDS analysis was performed to determine the 
presence of cisplatin in the fibers by observing peaks of 
platinum (Pt) and chlorine (Cl) in the spectrum, as shown 
in Figure 4B. The weight percentage of characteristic 
Table 1: Solution compositions used for electrospinning.
Solution  Material   Solvent   Concentration
A   Cisplatin   DMF   5 mg/ml
B   Cellulose pulp   NMMO.H2O   2 wt%
C   Cellulose acetate   Acetone+DMAc (2:1 
v/v)
  2 wt%
D   PEO   Deionized water+0.9 
wt% NaCl
  20 wt%
DMAc, dimethylacetamide; DMF, dimethylformamide; NMMO, 
N-methylmorpholine N-oxide; PEO, poly(ethylene oxide).
Table 2: Electrospinning parameters.
Materials   Solution   Feed rate (ml/h)   Voltage 
(kV)
  Collector 
distance (mm)
  Relative 
humidity (%)
  Sample morphology
Cellulose (neat)   B   0.03–0.1   22   100   60  Interconnected nanofibers
Cellulose+cisplatin  B+A   0.05–0.1   28   100   60  Particles attached to fiber surface
CA (neat)   C   0.5–1.0   25   150   35  Regular nanofibers
CA+cisplatin   Sheath: C 
Core: A
  0.5 (s); 
0.2 (c)
  15   150   35  Electrosprayed particles
    0.3 (s) 
0.2 (c)
  25   210   35  Highly branched fibers
    0.5 (s) 
0.2 (c)
  17–20   210   35  Fibers with beads
PEO (neat)   D   0.5   24   120   50  Regular nanofibers
PEO+cisplatin   Sheath: D
Core: A
  1.0 (s) 
0.2–0.6 (c)
  22   125   44  Nanofibers with repeating beads
c, core; s, sheath; CA, cellulose acetate.
elements of cellulose (C, O) and cisplatin (Pt, Cl) are also 
shown in Figure 4B, and it can be observed that the cis-
platin content compared to cellulose is too low. This can 
be attributed to the EDS spectrum being based on a single 
point scan.
Cellulose has poor solubility in conventional solvents 
and results in high viscosity of spinning dopes, due to its 
strong intermolecular hydrogen bonding network. Deriv-
atives of cellulose such as CA are easier to process, and 
are readily soluble in conventional solvents. The rate of 
evaporation of the polymer solvent during spinning can 
be optimized by mixing a higher volatility solvent (such 
as acetone) with a solvent of lower volatility (such as 
DMAc, acetic acid, DMF, water). The solvent characteris-
tics and CA concentration also affect the resultant fiber 
 morphology [47].
A solvent system of acetone and DMAc at a ratio of 
2:1  (v/v) was used for preparing the CA solutions. DMAc 
was added to increase the conductivity of the solution 
to be used for electrospinning. CA powder was slowly 
Figure 3: Scanning electron microscopy (SEM) image of neat cel-
lulose nanofibers.
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dissolved in the solvent mixture at a concentration of 
7.5 wt% under vigorous stirring with a homogenizer. Elec-
trospinning of CA solutions yielded a higher volume of 
nanofibers compared to the cellulose pulp solutions. The 
resulting neat CA nanofibers were uniform and randomly 
distributed with minimal defects, with a size distribution 
between 70 nm and 150 nm, as shown in Figure 5.
The coaxial electrospinning experiments for encap-
sulation of cisplatin in a CA-based sheath yielded three 
populations of samples with distinctive morphological 
features. The morphological development was affected 
by the electrospinning process parameters. The initial 
parameters consisted of a voltage of 15 kV, a sheath solu-
tion (CA) feed rate of 0.5 ml/h and a core solution (cis-
platin) feed rate of 0.2 ml/h. The tip-to-collector distance 
was maintained at 150 mm. A stable Taylor cone could 
not be obtained at these parameters, which subsequently 
resulted in electrospraying of the solution droplet. These 
effects resulted in the formation of crystalline straw-sheaf 
microstructures of CA conjugated with cisplatin, as shown 
in Figure 6. The size distribution of the microstructures 
Figure 4: (A) Formation of aggregates of cellulose and cisplatin particles on the fibers, (B) corresponding energy dispersive X-ray spectros-
copy (EDS) spectrum (scanning area shown in inset).
Figure 5: Scanning electron microscopy (SEM) image of neat cel-
lulose acetate nanofibers.
Figure 6: Scanning electron microscopy (SEM) image of electro-
sprayed cellulose acetate (CA)-cisplatin particles.
varied widely with sizes as small as 2–10 μm, and larger 
structures of 30–60 μm in length. A magnified SEM image 
of the straw-sheaf-like structure is shown in Figure 7A. 
The hierarchical microstructure is composed of a bundle 
of thin filaments clustered together with a narrow contrac-
tion in the middle. EDS analysis indicated the cisplatin 
content in the structure through the presence of Pt and Cl 
peaks in the EDS spectrum, as shown in Figure 7B. The cis-
platin particles were uniformly distributed on the struc-
ture, as shown by the EDS map of the Pt distribution given 
in the inset of Figure 7B.
The process parameters were subsequently adjusted 
to a higher voltage of 25 kV, while maintaining the solu-
tion feed rates of the sheath (CA) at 0.3 ml/h and core 
(cisplatin) at 0.2 ml/h. The tip-to-collector distance was 
kept at 210 mm. The compound Taylor cone exhibited a 
different mode of behavior upon application of a higher 
voltage. Extensive jet splaying and whipping instabilities 
were observed at the compound solution droplet. This 
set of parameters generated continuous nanofibers with 
repeating dendritic branched features aligned uniformly 
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on the deposition area, as shown in Figure 8. Each of 
the hierarchical structures are composed of periodically 
spaced branches of varying sizes of 7–20 μm in length, 
protruding from a long continuous main stem of 0.7–1 μm 
Figure 7: (A) Magnified scanning electron microscopy (SEM) image of the cellulose acetate (CA)-cisplatin straw-sheaf microstructure,  
(B) corresponding energy dispersive X-ray spectroscopy (EDS) spectrum (scanning area and Pt distribution map shown in inset).
Figure 8: Scanning electron microscopy (SEM) image of hierarchi-
cally branched microfibers of cellulose acetate (CA) loaded with 
cisplatin.
Figure 9: (A) Magnified scanning electron microscopy (SEM) image of sub-branches of cellulose acetate (CA)-cisplatin fibers, (B) corre-
sponding energy dispersive X-ray spectroscopy (EDS) spectrum (scanning area and Pt distribution map shown in inset).
in diameter. The sub-branches are further subdivided into 
more branches follwing a pattern similar to the aforemen-
tioned configuration. The main stems are arranged unidi-
rectionally in parallel and are spaced apart at distances 
varying from 17 μm to 25 μm. A magnified SEM image of 
the branching pattern is shown in Figure 9A. The hier-
archical structure is evident even at the nanoscale. The 
stems diameters vary from 75 nm to 100 nm, with protrud-
ing branches as small as 130–150 nm and larger branches 
of 300–700 nm in length. The diameters of the branches 
vary between 60 nm and 90 nm. EDS scan of an area of the 
branched structure indicated the presence of cisplatin, as 
shown in Figure 9B.
The formation of these highly branched hierarchical 
structures indicates the occurrence of branching effects 
both during drawing of the electrospinning jet and solidi-
fication of the fibers on the collector. The combined effect 
of extremely high electrical stresses and surface tension 
can generate complex static undulations on the surface 
of a conducting fluid jet. Such undulating sites on the jet 
surface can influence the formation of flow instabilities 
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leading to the emanation of lateral branches from the 
primary jet [48]. As shown by Holzmeister et al. [49], for-
mation of reguarly spaced barbs on nanofibers can be 
generated due to the competition between slow charge 
relaxation and the electrically driven surface instabilities 
on the electrospinning jet. When the disparity of the slow 
charge relaxation compared to the rate of growth of the 
secondary instabilities becomes more pronounced, the 
barbs can transform to full scale long branches. Factors 
leading to such disparities are influenced by the polymer 
solution conductivity and viscoelasticity. Addition of 
solvents with high dielectric constants such as DMF and 
DMAc into spinning solutions can induce extensive jet 
splaying during electrospinning. Hsu and Shivkumar [50] 
observed that addition of DMF in solutions of PCL in DCM 
caused initiation of jet splaying into multiple mini-jets 
almost immediately below the spinneret or needle tip. The 
jet-splitting effects also affected the resultant fiber mor-
phology, by generating multimodal size distributions in 
the produced fibers.
The fractal-like nature of the branching exhibited 
in Figure 9A also suggests the ocurrence of a dielectric 
breakdown in the fibers during solidification of the elec-
trospinning jet on the collector plate. These conductive 
paths resemble tree-like branched or dendritic features, 
also known as Lichtenberg figures [51]. The formation 
of the self-similar or fractal-like nature of the resultant 
structure can be explained by the process of “diffusion-
limited aggregation” [52]. In this process, particles under-
going diffusion in a medium aggregate around seed 
particles which act as nucleation centers. The repetitive 
process results in a highly branched cluster of particles, 
since the arriving particles are more likely to be attached 
to the tips of outer branches than maneuver towards the 
inner regions. New branches are also generated from each 
tip site, which result in the formation of a self-similar 
branched fractal stucture. Dawar and Chandra [53, 54] 
showed the effect of an external electric field in diffusion-
limited aggregation-influenced branched fractal forma-
tion in conductive polymer electrolytes dispersed with 
Al2O3 seed particles. The electric field allows the formation 
of ordered branched structures aligned along the electric 
field direction. Branched structure growth in this case is 
governed by a complex interplay of diffusion, migration 
and electroconvection.
In our experiment, when subjected to a substantially 
higher voltage of 25 kV, higher drawing forces on the com-
pound droplet ejected from the spinneret introduced a 
larger volume of the core cisplatin solution with the elec-
trospinning jet. Upon contact with the grounded collec-
tor, a rapid discharge of excess charges in the compound 
Figure 10: Swollen beads on cellulose acetate fibers loaded with 
cisplatin.
solution jet was initiated due to dielectric breakdown, 
resulting in the creation of electrically conductive paths 
along the surface of the fibers. Seed particles of cisplatin 
in the solution acted as nucleation centers for aggregation 
of more cisplatin particles as branched clusters. The EDS 
scanning map of the branched fibers shown in Figure 9B 
shows the elemental distribution of Pt, which supports 
the model of branched cluster formation of cisplatin parti-
cles. Finally, evaporation of the solvent yielded an ordered 
arrangement of highly branched CA fibers on the collector.
Further adjustment of the parameters generated 
a third population of fibers containing large beads, as 
shown in Figure 10. The voltage was varied between 17 kV 
and 20  kV and the sheath and core solution feed rates 
were maintained at 0.5 ml/h and 0.2 ml/h, respectively. 
The fibers ranged in size from 500 nm to 1 μm, with larger 
fibers between 2 μm and 6 μm. The larger fibers seem to 
be fused and interconnected with several adjacent fibers 
along their length.
A large bead present in the observed sample was per-
forated by increasing the SEM acceleration voltage and 
focusing the high intensity electron beam of the SEM at 
a single point on it. The subsequent degradation of the 
CA sheath of the bead exposed an inner layer of cisplatin 
particles dispersed within the interior of the solid bead, 
as shown in Figure 11A. An EDS scan of the bead site was 
performed which indicated encapsulation of the cisplatin 
particles within a layer of CA, shown in Figure 11B.
To summarize our observations regarding the mor-
phological evolution of structures from the coaxial elec-
trospinning of CA and cisplatin solutions, the parameters 
(applied voltage, sheath flow rate, tip-to-collector dis-
tance) were adjusted to enable the proper formation of 
fibers from the electrospinning jet, while also achieving 
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suitable encapsulation of the drug solution inside the 
sheath solution. The initial set of parameters (15 kV, 
25 kV) provided us the indication of the behavior of the 
compound solution during coaxial spinning at the lower 
and upper bounds, and their effects on sample fiber mor-
phology. For example, at 15  kV the compound solution 
led to electrospraying, which formed drug-loaded micro-
particles. At 25 kV, the solution formed highly branched 
drug-loaded fibers. These observations indicate that at 
lower voltages, viscoelastic effects overcome the electri-
cal stresses, while at extremely high voltages the electrical 
stresses play a much more dominant role in determining 
the fiber morphology. The population of fibers observed 
in Figure 10 was formed at a moderate voltage range of 
17–20 kV. At this set of parameters, the spinning jet was 
more stable and continuous, leading to the formation of 
randomly distributed beaded drug-loaded fibers.
For electrospinning experiments of PEO nanofibers, 
a 20 wt% PEO solution in deionized water was prepared 
under constant stirring with a magnetic stirrer. NaCl 
(0.9  wt%) was added to the deionized water to increase 
the solution conductivity. Neat PEO nanofibers were pro-
duced using single-nozzle electrospinning (parameters 
listed in Table 2). The resultant nanofibers were randomly 
distributed and showed uniform surface features. An SEM 
image of the neat PEO nanofibers is shown in Figure 12. 
The diameters of the nanofibers were widely distributed 
between 80 nm and 200 nm.
Coaxial electrospinning was subsequently performed 
to encapsulate cisplatin inside PEO nanofibers. The 
feed rate of the sheath was maintained at 1.0 ml/h, and 
the core solution feed rate was varied between 0.2 ml/h 
and 0.6 ml/h. Other process paramaters (voltage, collec-
tor distance, relative humidity) are listed in Table 2. The 
drug-loaded PEO nanofibers displayed the formation of 
sporadically spaced beaded structures along the length 
Figure 11: (A) Cisplatin particles dispersed inside a perforated bead of cellulose acetate (CA), (B) corresponding energy dispersive X-ray 
spectroscopy (EDS) spectrum (scanning area shown in inset).
Figure 12: Scanning electron microscopy (SEM) image of neat 
poly(ethylene oxide) (PEO) nanofibers.
of the fibers, as shown in Figure 13. The dumbbell-shaped 
features suggest the encapsulation of drug particles inside 
the PEO shell layer. The beads vary between 140 nm and 
170  nm and the connecting fibers vary between 45  nm 
and 70 nm in size. The magnified SEM image of Figure 14 
shows clear phase separation between the core and sheath 
layers. The sheath layer thickness ranged between 8 nm 
and 25 nm, while the core layer thickness ranged between 
43 nm and 108 nm in the beads, and 30 nm and 40 nm in 
the connecting nanofibers between the beads.
Core-sheath fiber formation is affected by the dif-
ference in conductivity between the sheath and core 
solutions. The core solution contains DMF, which is a 
polyelectrolytic solvent with higher conductivity than 
the sheath solution containing water. Compared to the 
sheath solution, the core solution experiences higher 
charge buildup, leading to increased extensional forces 
in the core solution due to surface charge repulsion. 
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Figure 14: Magnified scanning electron microscopy (SEM) image 
of cisplatin-loaded poly(ethylene oxide) (PEO) nanofibers showing 
formation of distinct core and sheath layers.
Figure 15: Formation of beaded structures due to jet breakup 
effects in core solution during coaxial electrospinning.
Figure 13: Drug-loaded poly(ethylene oxide) (PEO) nanofibers 
showing formation of repeating beads containing cisplatin.
Additionally, the viscosity and surface tension of the core 
solution are much lower than that of the shell solution, 
which render it incapable of forming fibers. A lower vis-
cosity core solution will thus initiate jet breakup during 
electrospinning [55]. For fiber formation with continuous 
core-shell structure using coaxial electrospinning, the core 
solution should be confined within the sheath through the 
effect of viscous drag. If the core solution is significantly 
lower in viscosity than the sheath, jet breakup of the core 
solution will occur. This effect will cause the core solution 
to be pulled intermittently inside the sheath. The sheath 
will then spread along its length and migrate towards the 
droplet to hold it inside a beaded structure. A schematic of 
this process is shown in Figure 15. As such, the reduction 
of size of the connecting nanofibers (15–20 nm) between 
the droplets compared to the neat PEO fibers (40–160 nm) 
can be attributed to the effects of droplet migration. Díaz 
et al. [56] described encapsulation of hydrophobic liquids 
in hydrophilic polymer nanofibers using coaxial electro-
spinning. They obtained nanofibers which encapsulated 
oil within periodically spaced beads. The inner oil did not 
form a continuous core, but a string of discrete pockets. 
The inner jet (oil) of the compound Taylor cone being a 
Newtonian liquid, underwent varicose break-up at a 
faster rate than the solidification of the outer sheath, even 
though the small interfacial tension and the high viscos-
ity of the outer liquid slowed down the break-up process. 
They found that the bead-to-bead distance and fiber 
diameter may be controlled by the outer liquid flow rate, 
while the bead diameter may be controlled by adjusting 
the inner liquid flow rate.
4  Conclusion
Micro- and nanoscale fibers of cellulose, CA and PEO were 
fabricated using electrospinning. A model anti-cancer/
tumor drug, cis-diammineplatinum (II) dichloride (cispla-
tin) was encapsulated in the fibers using coaxial electro-
spinning. Morphological analysis of the various categories 
of fibers was performed using SEM and EDS. The fibers 
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exhibited diverse morphological features depending on 
the material compositions and process parameters. Drug-
loaded cellulose nanofibers showed particles composed 
of both cellulose and cisplatin attached to the surface. 
The CA-cisplatin fibers exhibited drug encapsulation 
within various diverse morphological configurations 
composed of swollen fibers and hierarchical structures 
of straw-sheaf like microparticles and branched fibers. 
Nanofibers of PEO showed encapsulation of drug inside 
repeating dumbbell-shaped structures formed along the 
length of the nanofibers. The morphological character-
istics and manner of drug encapsulation were correlated 
with process parameters such as applied voltage, concen-
trations and relative feed rates of the solutions and con-
ductivities of the solvents.
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